E. coli-derived recombinant human protein (amino acids M1-L350) was used as the immunogen for the SLC35E4 antibody.
Solute carrier family 35 member E4 is predicted to enable antiporter activity. Predicted to be involved in transmembrane transport. Predicted to be integral component of membrane. Predicted to be active in Golgi apparatus.